Reviewed,
UniProtKB/Swiss-Prot Q01094 (E2F1_HUMAN)
Last modified
November 25, 2008.
Version 104.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Transcription factor E2F1 Short name=E2F-1 Alternative name(s): Retinoblastoma-binding protein 3 Short name=RBBP-3 PRB-binding protein E2F-1 PBR3 Retinoblastoma-associated protein 1 Short name=RBAP-1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 437 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Transcription activator that binds DNA cooperatively with dp proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F-1 binds preferentially RB1 protein, in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent apoptosis. |
| Subunit structure | Component of the DRTF1/E2F transcription factor complex. Forms heterodimers with DP family members. The E2F-1 complex binds specifically hypophosphorylated retinoblastoma protein RB1. During the cell cycle, RB1 becomes phosphorylated in mid-to-late G1 phase, detaches from the DRTF1/E2F complex, rendering E2F transcriptionally active. Viral oncoproteins, notably E1A, T-antigen and HPV E7, are capable of sequestering RB protein, thus releasing the active complex. Interacts with TRRAP, which probably mediates its interaction with histone acetyltransferase complexes, leading to transcription activation. Binds TOPBP1 and EAPP. Interacts with ARID3A. |
| Subcellular location | |
| Post-translational modification | Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase. |
| Sequence similarities | Belongs to the E2F/DP family. |
Ontologies
Keywords | |
|---|---|
| Biological process | Apoptosis Cell cycle Transcription Transcription regulation |
| Cellular component | Nucleus |
| Coding sequence diversity | Polymorphism |
| Ligand | DNA-binding |
| Molecular function | Activator |
| PTM | Phosphoprotein |
| Technical term | 3D-structure |
Gene Ontology (GO) | |
| Biological process | G1 phase of mitotic cell cycle Traceable author statement. Source: ProtInc apoptosisTraceable author statement. Source: ProtInc cell proliferationTraceable author statement. Source: ProtInc negative regulation of transcription from RNA polymerase II promoterTraceable author statement. Source: ProtInc |
| Cellular component | transcription factor complex Inferred from electronic annotation. Source: InterPro |
| Molecular function | transcription corepressor activity Traceable author statement. Source: ProtInc transcription factor activity Ref.17Inferred from direct assay. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| DDB2 | Q92466 | 2 | EBI-448924,EBI-1176171 | |
| PA2G4 | Q9UQ80 | 1 | EBI-448924,EBI-924893 | |
| PARP1 | P09874 | 2 | EBI-448924,EBI-355676 | |
| PRMT2 | P55345 | 1 | EBI-448924,EBI-78458 | |
| RB1 | P06400 | 1 | EBI-448924,EBI-491274 | |
| SP1 | P08047 | 2 | EBI-448924,EBI-298336 | |
| Sp1 | O89090 | 1 | EBI-448924,EBI-645192 | From a different organism. |
| TRRAP | Q9Y4A5 | 1 | EBI-448924,EBI-399128 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 437 | 437 | Transcription factor E2F1 | PRO_0000219461 | |||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||
| Domain | 153 – 174 | 22 | Leucine-zipper | ||||||||||||||||||||||||||
| DNA binding | 110 – 194 | 85 | Potential | ||||||||||||||||||||||||||
| Region | 67 – 108 | 42 | Cyclin A/CDK2 binding | ||||||||||||||||||||||||||
| Region | 195 – 284 | 90 | Dimerization Potential | ||||||||||||||||||||||||||
| Region | 368 – 437 | 70 | Transactivation | ||||||||||||||||||||||||||
| Region | 409 – 426 | 18 | Retinoblastoma protein RB1 binding Potential | ||||||||||||||||||||||||||
| Motif | 158 – 194 | 37 | DEF box | ||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||
| Modified residue | 375 | 1 | Phosphoserine | ||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||
| Natural variant | 252 | 1 | R → H: dbSNP rs3213172. | VAR_013607 | |||||||||||||||||||||||||
| Natural variant | 276 | 1 | V → M: dbSNP rs3213173. | VAR_013608 | |||||||||||||||||||||||||
| Natural variant | 311 | 1 | T → N: dbSNP rs3213174. | VAR_013609 | |||||||||||||||||||||||||
| Natural variant | 393 | 1 | G → S: dbSNP rs3213176. | VAR_013610 | |||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||
| Mutagenesis | 411 | 1 | Y → C: No retinoblastoma protein binding | ||||||||||||||||||||||||||
| Sequence conflict | 89 – 111 | 23 | KRRLD…PARGR → RTPGTPRRQRRLCPPRRPGR APC Ref.8 | ||||||||||||||||||||||||||
| Sequence conflict | 313 | 1 | S → Y in AAC50719. Ref.4 | ||||||||||||||||||||||||||
| Sequence conflict | 322 | 1 | N → T in AAC50719. Ref.4 | ||||||||||||||||||||||||||
| Sequence conflict | 329 | 1 | T → N in AAC50719. Ref.4 | ||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||
| Helix | 202 – 236 | 35 | |||||||||||||||||||||||||||
| Helix | 238 – 243 | 6 | |||||||||||||||||||||||||||
| Beta strand | 245 – 247 | 3 | |||||||||||||||||||||||||||
| Helix | 248 – 252 | 5 | |||||||||||||||||||||||||||
| Turn | 257 – 259 | 3 | |||||||||||||||||||||||||||
| Beta strand | 260 – 266 | 7 | |||||||||||||||||||||||||||
| Beta strand | 272 – 277 | 6 | |||||||||||||||||||||||||||
| Beta strand | 282 – 287 | 6 | |||||||||||||||||||||||||||
| Beta strand | 289 – 291 | 3 | |||||||||||||||||||||||||||
| Beta strand | 294 – 296 | 3 | |||||||||||||||||||||||||||
| Helix | 421 – 424 | 4 | |||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F." Helin K., Lees J.A., Vidal M., Dyson N.J., Harlow E., Fattaey A. Cell 70:337-350(1992) [PubMed: 1638634] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties." Kaelin W.G. Jr., Krek W., Sellers W.R., Decaprio J.A., Ajchenbaum F., Fuchs C.S., Chittenden T., Li Y., Farnham P.J., Blanar M.A., Livingston D.M., Flemington E.K. Cell 70:351-364(1992) [PubMed: 1638635] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F." Shan B., Zhu X., Chen P.L., Durfee T., Yang Y., Sharp D., Lee W.H. Mol. Cell. Biol. 12:5620-5631(1992) [PubMed: 1448092] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | "Structure and partial genomic sequence of the human E2F1 gene." Neuman E., Sellers W.R.S., McNeil J.A., Lawrence J.B., Kaelin W.G. Jr. Gene 173:163-169(1996) [PubMed: 8964493] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Rieder M.J., Livingston R.J., Braun A.C., Montoya M.A., Chung M.-W., Miyamoto K.E., Nguyen C.P., Nguyen D.A., Poel C.L., Robertson P.D., Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A. Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS HIS-252; MET-276; ASN-311 AND SER-393. |
| [6] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Pancreas and Skin. |
| [8] | "Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression." Johnson D.G., Ohtani K., Nevins J.R. Genes Dev. 8:1514-1525(1994) [PubMed: 7958836] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-111. |
| [9] | "Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein." Helin K., Harlow E., Fattaey A. Mol. Cell. Biol. 13:6501-6508(1993) [PubMed: 8413249] [Abstract] Cited for: TRANSACTIVATION INHIBITION, MUTAGENESIS OF TYR-411. |
| [10] | "Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase." Krek W., Ewen M.E., Shirodkar S., Arany Z., Kaelin W.G. Jr., Livingston D.M. Cell 78:161-172(1994) [PubMed: 8033208] [Abstract] Cited for: DOMAIN CYCLIN A/CDK2 BINDING. |
| [11] | "Differential regulation of E2F transactivation by cyclin/cdk2 complexes." Dynlacht B.D., Flores O., Lees J.A., Harlow E. Genes Dev. 8:1772-1786(1994) [PubMed: 7958856] [Abstract] Cited for: DIFFERENTIAL REGULATION BY CYCLIN/CDK2 KINASES. |
| [12] | "Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation." Xu M., Sheppard K.-A., Peng C.-Y., Yee A.S., Piwnica-Worms H. Mol. Cell. Biol. 14:8420-8431(1994) [PubMed: 7969176] [Abstract] Cited for: INHIBITION OF DNA-BINDING. |
| [13] | "P53 and E2F-1 cooperate to mediate apoptosis." Wu X., Levine A.J. Proc. Natl. Acad. Sci. U.S.A. 91:3602-3606(1994) [PubMed: 8170954] [Abstract] Cited for: FUNCTION IN APOPTOSIS. |
| [14] | "Phosphorylation of E2F-1 by cyclin A-cdk2." Kitagawa M., Higashi H., Suzuki-Takahashi I., Segawa K., Hanks S.K., Taya Y., Nishimura S., Okuyama A. Oncogene 10:229-236(1995) [PubMed: 7838523] [Abstract] Cited for: PHOSPHORYLATION. |
| [15] | "Specific regulation of E2F family members by cyclin-dependent kinases." Dynlacht B.D., Moberg K., Lees J.A., Harlow E., Zhu L. Mol. Cell. Biol. 17:3867-3875(1997) [PubMed: 9199321] [Abstract] Cited for: REGULATION BY CYCLIN-DEPENDENT KINASES. |
| [16] | "A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer." Suzuki M., Okuyama S., Okamoto S., Shirasuna K., Nakajima T., Hachiya T., Nojima H., Sekiya S., Oda K. Oncogene 17:853-865(1998) [PubMed: 9780002] [Abstract] Cited for: INTERACTION WITH ARID3A. |
| [17] | "E2F transcriptional activation requires TRRAP and GCN5 cofactors." Lang S.E., McMahon S.B., Cole M.D., Hearing P. J. Biol. Chem. 276:32627-32634(2001) [PubMed: 11418595] [Abstract] Cited for: INTERACTION WITH TRRAP. |
| [18] | "Regulation of E2F1 by BRCT domain-containing protein TopBP1." Liu K., Lin F.-T., Ruppert J.M., Lin W.-C. Mol. Cell. Biol. 23:3287-3304(2003) [PubMed: 12697828] [Abstract] Cited for: INTERACTION WITH TOPBP1. |
| [19] | "EAPP, a novel E2F binding protein that modulates E2F-dependent transcription." Novy M., Pohn R., Andorfer P., Novy-Weiland T., Galos B., Schwarzmayr L., Rotheneder H. Mol. Biol. Cell 16:2181-2190(2005) [PubMed: 15716352] [Abstract] Cited for: INTERACTION WITH EAPP. |
| [20] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, MASS SPECTROMETRY. Tissue: Epithelium. |
| [21] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, MASS SPECTROMETRY. |
| [22] | "Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A." Lowe E.D., Tews I., Cheng K.Y., Brown N.R., Gul S., Noble M.E.M., Gamblin S.J., Johnson L.N. Biochemistry 41:15625-15634(2002) [PubMed: 12501191] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 87-95. |
| [23] | "Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation." Xiao B., Spencer J., Clements A., Ali-Khan N., Mittnacht S., Broceno C., Burghammer M., Perrakis A., Marmorstein R., Gamblin S.J. Proc. Natl. Acad. Sci. U.S.A. 100:2363-2368(2003) [PubMed: 12598654] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 409-426 IN COMPLEX WITH RB1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M96577 mRNA. Translation: AAA35782.1. U47677, U47675, U47676 Genomic DNA. Translation: AAC50719.1. S49592 mRNA. Translation: AAB24289.1. Different initiation. AF516106 Genomic DNA. Translation: AAM47604.1. AL121906 Genomic DNA. Translation: CAC08486.1. BC050369 mRNA. Translation: AAH50369.1. BC058902 mRNA. Translation: AAH58902.1. S74230 Genomic DNA. Translation: AAD14150.1. | |||||||||||||||||||||||||
| PIR | JC4929. | ||||||||||||||||||||||||
| RefSeq | NP_005216.1. | ||||||||||||||||||||||||
| UniGene | Hs.654393 | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| SMR | Q01094. Positions 126-190. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP:200N. DIP:24227N. DIP:498N. | ||||||||||||||||||||||||
| IntAct | Q01094. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q01094. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| NIEHS-SNPs | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSG00000101412. Homo sapiens. [Contig view] | ||||||||||||||||||||||||
| GeneID | 1869. | ||||||||||||||||||||||||
| KEGG | hsa:1869. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| H-InvDB | HIX0027663. | ||||||||||||||||||||||||
| HGNC | HGNC:3113. E2F1. | ||||||||||||||||||||||||
| HPA | CAB000120. CAB000329. | ||||||||||||||||||||||||
| MIM | 189971. gene. | ||||||||||||||||||||||||
| PharmGKB | PA152. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| HOVERGEN | Q01094. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_152. Cell Cycle, Mitotic. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q01094. | ||||||||||||||||||||||||
| CleanEx | HS_E2F1. | ||||||||||||||||||||||||
| GermOnline | ENSG00000101412. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR015633. E2F. IPR015634. E2F1. IPR003316. E2F_TDP. IPR011991. W | ||||||||||||||||||||||||

Clusters with